Skip to main content
Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation

Fig. 3

Concordance between biomarkers in groups defined by clinical or amyloid-PET. ad groups classified by clinical. eh groups classified by amyloid-PET. Scatter plot: a, e42 versus T-tau, b, f42 versus T-tau/α-syn, c, g42/P-tau181 versus T-tau, and d, h42/P-tau181 versus T-tau/α-syn. Vertical and horizontal dashed lines indicate the cutoff of each biomarker

Back to article page
\